DOCS Feb 2023 22.500 put
| Previous close | 0.0500 |
| Open | 0.0500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 22.50 |
| Expiry date | 2023-02-17 |
| Day's range | 0.0500 - 0.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
The shares for Doximity (NYSE: DOCS), Iqvia Holdings (NYSE: IQV), and TransMedics Group (NASDAQ: TMDX) are all off to positive starts this year, but what makes them different from other companies is that they are changing healthcare industry standards. Doximity is becoming a must for physicians thanks to its helpful applications. While technology has been a big part of medicine for a long time, the actual connection between doctors and patients is still stuck in the last century, with 80% of all healthcare documents sent by regular mail or fax.
- Zacks
AMN or DOCS: Which Is the Better Value Stock Right Now?
AMN vs. DOCS: Which Stock Is the Better Value Option?
- Motley Fool
Why Doximity's Shares Are Up This Week
Shares of Doximity (NYSE: DOCS) rose 13.5% this week as of Thursday's close, according to data provided by S&P Global Market Intelligence. The company, which provides a digital platform for healthcare professionals, has a 52-week low of $22.91 and a 52-week high of $64.95. The healthcare company is due to report earnings on Feb. 9.
